insights_auto
Why is ALNOV up 4,65%?
Dive Deeperchevron_right
ALNOV:EPA
Novacyt SA
0,45 €
arrow_upward
+4,65%(+0,020) 1D
13-ноя., 17:35:28 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,44 €
High
0,46 €
Low
0,43 €
Mkt. cap
30,13 млн
Avg. vol.
164,75 миң
Volume
156,80 миң
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
Open
0,44 €
High
0,46 €
Low
0,43 €
Mkt. cap
30,13 млн
Avg. vol.
164,75 миң
Volume
156,80 миң
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
News stories
From web sources and news partners
The Motley Fool
·
1 саат мурун
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
BigGo Finance
·
2 саат мурун
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
StoneX
·
2 күн мурун
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Traders Union
·
5 саат мурун
Quinten Francois: Bitcoin and Ethereum underperform S&P 500 over five years
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
Founded2006-ж., 3-июл.
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com